Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration

To study retinal pigment epithelium (RPE) tears after off-label intravitreal bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) injection for neovascular age-related macular degeneration. Eyes with a vascularized pigment epithelial detachment (PED) that developed an RPE tear were compar...

Full description

Saved in:

Bibliographic Details
Published in:	Retina (Philadelphia, Pa.) Vol. 27; no. 5; p. 541
Main Authors:	Chan, Clement K, Meyer, Carsten H, Gross, Jeffrey G, Abraham, Prema, Nuthi, Asha S D, Kokame, Gregg T, Lin, Steven G, Rauser, Michael E, Kaiser, Peter K
Format:	Journal Article
Language:	English
Published:	United States 01.06.2007
Subjects:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Bevacizumab Choroidal Neovascularization - drug therapy Female Fluorescein Angiography Humans Injections Macular Degeneration - drug therapy Male Pigment Epithelium of Eye - drug effects Pigment Epithelium of Eye - pathology Retinal Detachment - chemically induced Retinal Detachment - diagnosis Retinal Perforations - chemically induced Retinal Perforations - diagnosis Retrospective Studies Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Vitreous Body
ISSN:	0275-004X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!